Teijin : Notice Concerning Completion of Payment for the Disposal of Treasury Shares as "Restricted Stock"
August 04, 2021 at 03:06 am EDT
Share
August 4, 2021
To Whom It May Concern:
Company: Teijin Limited
Representative: Jun Suzuki, President and CEO
Stock code: 3401 (First Section, Tokyo Stock Exchange)
Contact: Tomoko Torii, General Manager,
Investor Relations Department
TEL: +81335064395
Notice Concerning Completion of Payment for the Disposal of Treasury Shares as
"Restricted Stock"
Teijin Limited (the "Company") hereby announces that it has completed the payment procedure today as described below regarding the disposal of treasury shares as "Restricted Stock" as resolved at the Board of Directors meeting held on July 13, 2021. For details regarding the disposal, please refer to "Notice Concerning the Disposal of Treasury Shares as "Restricted Stock"" issued on July 13, 2021.
Overview of the Disposal of Treasury Shares
(1)
Class and number of
95,921 ordinary shares of the Company
shares for disposal
(2)
Disposal price
¥1,649 per share
(3)
Total value of disposal
¥158,173,729
(4)
Allottees and number
Directors
(excluding the Chairman of the Board, Senior Advisor and Outside
thereof, and number of
Director),
6 persons, 26,138 shares
shares for disposal
Teijin Group Corporate Officers not concurrently serving as Directors, 21 persons,
49,584 shares
Executive Officers of overseas Group companies, 14 persons, 20,199shares
(5)
Date of disposal
August 4, 2021
Attachments
Original document
Permalink
Disclaimer
Teijin Limited published this content on 04 August 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2021 07:05:05 UTC.
Teijin Limited is a diversified group organized around 5 areas of activity:
- manufacturing and distribution of textile products and clothes (37.6% of net sales): textile fibers, polyesters, polymers, etc.;
- production of synthetic fibers (35.5%): aramid, carbon and polyester fibers for industrial applications;
- manufacturing of care and health products (17.8%): medicines (for the treatment of metabolic, cardiovascular, bone, joint and respiratory diseases), and home care equipments (home oxygen therapy equipments and positive pressure fans);
- sale of IT products and services (6.9%);
- other (2.2%).
Net sales break down geographically as follows: Japan (58.6%), China (13.1%), Asia (6.9%), Americas (13.7%) and other (7.7%).